A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new UCLA Health study.
Studies Examine Links Between Diabetes and Eye Disease, Treatment, Adverse Events
SEATTLE — Diabetic patients treated with GLP-1 agonists had significantly more progression of existing diabetic eye disease as compared with those treated with SGLT2 inhibitors,
August 1, 2023